News & Perspective

(CIDRAP News) – A standard dose of H1N1 influenza vaccine appears to work well in people who have asthma, but older patients with severe asthma may need a higher dose, a government-sponsored trial has shown.

(CIDRAP News) – With most Americans already possessing some degree of immunity to the 2009 H1N1 virus, the history of pandemics suggests that it's not very likely to make a big comeback anytime soon, according to three experts at the US National Institute of Allergy and Infectious Diseases (NIAID).

(CIDRAP News) – An experimental malaria drug that has a different mechanism from older drugs cured laboratory mice with a single dose, raising hope for eventually providing a powerful new weapon against the disease in humans.